Veröffentlichungen 2007
Athanassiadi K, Reiffen HP, Dickgreber N, Laenger F, Eschenbruch CM, Wilchelmi M, Haverich A:
A different surgical approach for an intrathoracic expanding hematoma.
J Thoracic Cardiovasc Surg 2007; 133(3): 832-4
Balkow S, Krux F, Loser K, Becker JU, Grabbe S, Dittmer U:
Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells.
Blood 2007; 110(12): 3949-58
Becker JU, Hoerning A, Schmid KW, Hoyer PF:
Immigrating progenitor cells contribute to human podocyte turnover.
Kidney Int 2007; 72(12): 1468-73
Bock O, Hussein K, Brakensiek K, Buhr T, Schlué J, Wiese B, Kreipe H:
The Suppressor of Cytokine Signalling -1 (SOCS-1) gene is overexpressed in Philadelphia chromosome negative
chronic myeloproliferative disorders.
Leuk Res 2007; 31(6): 799-803
Bock O, Hussein K, Kreipe H:
Stem cell defects in Philadelphia chromosome negative chronic myeloproliferative disorders
- a phenotypic and molecular puzzle?
Current Stem Cell Research & Therapy 2007; 2(3): 253-263 (Review)
Brakensiek K, Wingen LU, Länger F, Kreipe H, Lehmann U:
Quantitative high resolution CpG island mapping using PyrosequencingTM reveals disease-specific methylation patterns
of the CDKN2B gene in Myelodysplastic Syndrome and Myeloid Leukemia.
Clin Chem 2007; 53(1): 17-23
Büsche G, Ganser A, Schlegelberger B, von Neuhoff N, Gadzicki D, Hecker H, Bock O, Frye B, Kreipe H:
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia.
Leukemia 2007; 21(12): 2420-7
Büsche G, Hussein K, Bock O, Kreipe H:
Insights into JAK2-V617F mutation in CML.
Lancet Oncology 2007; 8(10): 863-4
Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H, Lehmann U:
Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.
Mol Cell Biochem 2007; 306(1-2): 201-12
Christgen M, Lehmann U:
MDA-MB-435: The questionable use of a melanoma cell line as a model for human breast cancer is going on.
Cancer Biol Ther 2007; 6(9): 1355-7 [Übersicht]
Clewing JM, Antalfy BC, Lucke T, Najafian B, Marwedel KM, Hori A, Powel RM, Safo Do AF, Najera L, SantaCruz K, Hicks MJ, Armstrong DL, Boerkoel CF:
Schimke immuno-osseous dysplasia: a clinicopathological correlation.
J Med Genet 2007; 44(2): 122-30
Diensthuber M, Ilner T, Rodt T, Lenarz T, Samii M, Brandis A, Stöver T:
Erythropoietin and Erythropoietin Receptor Expression in Vestibular Schwannoma: Potential Role in Tumor Progression.
Otology & Neurotology 2007; 28(4): 559-565
Dietel M, Ellis I, Höfler H, Kreipe H, Moch H, Dankof A, Kölble K, Kristiansen G:
Comparison of automated silver enhanced in-situ hybridisation (SISH) and fluorescence-ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists.
Virchow's Arch 2007; 451(1): 19-25
Divchev D, Podewski EK, Mengel M, Meyer GP, Drexler H, Schaefer A:
Inflammatory, abscess-forming foreign body reaction mimics a thrombus formation on an atrial septal
defect closure device: A commented case report.
Eur J Echocardiogr 2007; 8(4): 298-302
Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH:
Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
Pediatr Nephrol 2007; 22(4): 600-2
Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H, Christgen M, von Wasielewski R, Kreipe H:
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer.
Modern Pathology 2007; 20(8): 864-870
Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F, Greten TF:
Necrotic tumor cell death in vivo impairs tumor-specific immune responses.
J Immunol 2007; 178(3): 1573-80
Gawenda J, Traub F, Lück HJ, Kreipe HH, von Wasielewski R:
Legumain expression as a prognostic factor in breast cancer patients.
Breast Cancer Res Treat 2007; 102(1): 1-6
Göhring G, Karow A, Steinemann D, Wilkens L, Lichter P, Zeidler C, Niemeyer C, Welte K, Schlegelberger B:
Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?.
Ann Hematol 2007; 86(10): 733-96
Gwinner W, Erdbruegger U, Mengel M, Hafer C, Kittner J, Witte T, Voelker B, Haller H:
Scleroderma-like acute renal crisis in a patient with scleromyxedema.
Nephrol Dial Transplant 2007; 22(7): 2063-7
Haasper C, Laenger F, Rosenthal H, Knobloch KI, Moessinger E, Krettek C, Bastian L:
Coccydynia due to a Benign Notochordal Cell Tumor.
Spine 2007; 32: 394-6
Hadem J, Cornberg M, Länger F, Schedel I, Kirchhoff T, Niedermeyer J, Manns MP, Schöfl C:
Making sense of muscle fatigue and liver lesions.
Z Gastroenterol 2007; 45(7): 609-11
Hentschel DM, Mengel M, Boehme L, Liebsch F, Albertin C, Bonventre JV, Haller H, Schiffer M:
Rapid screening of glomerular slit diaphragm integrity in larval zebrafish.
Am J Physiol Renal Physiol 2007; 293(5): 1746-50
Hesse E, Moessinger E, Rosenthal H, Laenger F, Brabant G, Petrich T, Gratz KF, Bastian L:
Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
J Bone Miner Res 2007; 22(1): 158-62
Höinghaus R, von Wasielewski R, Hewicker-Trautwein M, Freund M, Mischke R:
Immunocytological detection of lymph node metastases in dogs with malignant epithelial tumours.
J Comp Pathol 2007; 137(1): 1-8
Hussein K, Bock O, Ballmaier M, Göhring G, Steinemann D, Lehmann U, Kemper J, Buhr T, Kreipe H:
Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis.
Leukemia 2007; 21(12): 2566-8 [case report]
Hussein K, Bock O, Kreipe H:
Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2:
persistance of old questions despite new answers.
Pathobiology 2007; 74(2): 72-80 [Übersicht]
Hussein K, Bock O, Seegers A, Flasshove M, Henneke F, Buesche G, Kreipe H:
Myelofibrosis evolving during Imatinib treatment of a chronic myeloproliferative disease with co-existing BCR-ABL translocation and JAK2V617F mutation.
Blood 2007; 109(9): 4106-7 [case report]
Hussein K, Brakensiek K, Buesche G, Buhr T, Wiese B, Kreipe H, Bock O:
Different involvement of the megakaryocytic lineage by the JAK2 (V617F) mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
Ann Haematol 2007; 86(4): 245-53
Ikuerowo SO, Kuczyk MA, von Wasielewski R, Shittu OB, Jonas U, Machtens S, Serth J:
p16INK4a expression and clinicopathologic parameters in renal cell carcinoma.
Eur Urol 2007; 51(3): 732-7
Imkamp F, von Wasielewski R, Musholt TJ, Musholt PB:
Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts.
J Surg Res 2007; 143(2): 350-63
Jonigk D, Lehmann U, Stuht S, Wilhelmi M, Haverich A, Kreipe H, Mengel M:
Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allograft.
Transplantation 2007; 84(10): 1335-42
Koch M, Mengel M, Poehnert D, Nashan B:
Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients.
Transplantation 2007; 83(4): 498-505
Kumpers P, Gueler F, Rong S, Mengel M, Tossidou I, Peters I, Haller H, Schiffer M:
Leptin is a co-activator of TGF-{beta} in unilateral ureteral obstructive kidney disease.
Am J Physiol Renal Physiol 2007; 293(4): 1355-62
Lechel A, Holstege H, Begus Y, Schienke A, Kamino K, Lehmann U, Kubicka S, Schirmacher P, Jonkers J,
Rudolph KL:
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Gastroenterology 2007; 132(4): 1465-1475
Lehmann U, Wingen LU, Brakensiek K, Wedemeyer HH, Becker T, Heim A, Metzig K, Hasemeier B, Kreipe H,
Flemming P:
Aberrant DNA methylation is a frequent event in hereditary haemochromatosis and precedes cirrhosis.
Hum Mol Genet 2007; 16(11): 1335-1342
Lenarz M, Durisin M, Becker H, Brandis A, Lenarz T:
A case of multiple primary tumors of the anterior skull base.
Skull Base 2007; 17(2): 153-6
Lenarz M, Durisin M, Kamenetzki P, Becker H, Kreipe HH, Lenarz T:
Cavernous hemangioma of the internal auditory canal.
Eur Arch Otorhinolaryngol 2007; 264(5): 569-571
Ma B, von Wasielewski R, Lindenmaier W, Dittmar KE:
Immmunohistochemical study of the blood and lymphatic vasculature and the innervation of mouse gut and gut-associated lymphoid tissue.
Anat Histol Embryol 2007; 36(1): 62-74
Meier M, Beigel A, Schiffer L, Lotz J, Hiss M, Mengel M, Haller H, Schwarz A:
Magnetic resonance (MR) imaging in a patient with chronic lithium nephropathy.
Nephrol Dial Transplant 2007; 22(1): 278-9
Meier M, Menne J, Park JK, Holtz M, Gueler F, Kirsch T, Schiffer M, Mengel M, Lindschau C, Leitges M, Haller H:
Deletion of Protein Kinase C-{varepsilon} Signaling Pathway Induces Glomerulosclerosis and Tubulointerstitial Fibrosis In Vivo.
J Am Soc Nephrol. 2007; 18(4): 1190-1198
Mengel M, Chapman JR, Cosio FG, Cavaille-Coll MW, Haller H, Halloran PF, Kirk AD, Mihatsch MJ, Nankivell BJ, Racusen LC, Roberts IS, Rush DN, Schwarz A, Seron D, Stegall MD, Colvin RB:
Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis.
Am J Transplant 2007; 7(3): 512-517
Mengel M, Gwinner W, Schwarz A, Bajeski R, Franz I, Bröcker V, Becker T, Neipp M, Klempnauer J, Haller H, Kreipe H:
Infiltrates in protocol biopsies from renal allografts.
Am J Transplant 2007; 7(2): 356-65
Menne J, Park JK, Shushakova N, Mengel M, Meier M, Fliser D:
The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury.
J Am Soc Nephrol 2007; 18(7): 2046-53
Merseburger AS, Serth J, von der Heyde E, Kobierski A, Wegener U, Mengel M, Jonas U, Kuczyk M:
Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
Urol Int 2007; 79(2): 164-9
Meyer TN, Schwesinger C, Wahlefeld J, Dehde S, Kerjaschki D, Becker JU, Stahl RA, Thaiss F:
A new mouse model of immune-mediated podocyte injury.
Kidney Int 2007; 72(7): 841-52
Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP, Roncalli M, Rudolph KL:
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.
Hepatology 2007; 45(4): 968-76
Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ.
Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy ('CAN').
Am J Transplant 2007; 7(3): 518-26
Steimle C, Lehmann U, Temerinac S, Goerttler PS, Kreipe H, Meinhardt G, Heimpel H, Pahl HL:
Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F.
Ann Hematol 2007; 86(4): 239-44
Stuht S, Gwinner W, Franz I, Schwarz A, Jonigk D, Kreipe H, Kerjaschki D, Haller H, Mengel M:
Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies.
Am J Transplant 2007; 7(2): 377-84
Winter C, Taut K, Länger F, Mack M, Briles DE, Paton JC, Maus R, Srivastava M, Welte T, Maus U:
FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to S. pneumoniae infection in mice: role of dendritic cells.
J Immunol 2007; 178(9): 5828-5838
Winter C, Taut K, Srivastava M, Länger F, Mack M, Briles DE, Paton JC, Maus R, Welte T, Gunn MD, Maus UA:
Lung-specific overexpression of CCL2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis.
J Immunol 2007; 178: 5828-38
Woywodt A, Hellweg S, Schwarz A, Schaefer RM, Mengel M:
A wild zebra chase.
Nephrol Dial Transplant 2007; 22(10): 3074-7
Ye FC, Blackbourn DJ, Mengel M, Xie JP, Qian LW, Greene W, Yeh IT, Graham D, Gao SJ:
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.
J Virol 2007; 81(8): 3980-3991